BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 366454)

  • 21. A randomized sequential trial of creatine in amyotrophic lateral sclerosis.
    Groeneveld GJ; Veldink JH; van der Tweel I; Kalmijn S; Beijer C; de Visser M; Wokke JH; Franssen H; van den Berg LH
    Ann Neurol; 2003 Apr; 53(4):437-45. PubMed ID: 12666111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trial of oral physostigmine in amyotrophic lateral sclerosis.
    Norris FH; Tan Y; Fallat RJ; Elias L
    Clin Pharmacol Ther; 1993 Dec; 54(6):680-2. PubMed ID: 8275623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical immunoadjuvant studies with tilorone, DEAA fluorene (RMI 11,002da), and Corynebacterium parvum and some observations on the role of host resistance and herpes-like lesions in tumor growth.
    Regelson W
    Ann N Y Acad Sci; 1976; 277(00):269-87. PubMed ID: 187101
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
    Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
    Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolongation of allografts in animals with a new agent: tilorone.
    Wildstein A; Stevens L; Applebaum H; McCabe R; Hashim G; Fitzpatrick H
    Proc Clin Dial Transplant Forum; 1975 Nov; 5():47-50. PubMed ID: 785462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.
    Weber M; Goldman B; Truniger S
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1135-40. PubMed ID: 20498181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group.
    Miller RG; Moore D; Young LA; Armon C; Barohn RJ; Bromberg MB; Bryan WW; Gelinas DF; Mendoza MC; Neville HE; Parry GJ; Petajan JH; Ravits JM; Ringel SP; Ross MA
    Neurology; 1996 Dec; 47(6):1383-8. PubMed ID: 8960715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group.
    Neurology; 1996 May; 46(5):1244-9. PubMed ID: 8628460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Brooke MH; Florence JM; Heller SL; Kaiser KK; Phillips D; Gruber A; Babcock D; Miller JP
    Neurology; 1986 Feb; 36(2):146-51. PubMed ID: 3080694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of severe epithelial dysplasia of esophagus. I. Therapeutic effects of Antitumor B III, Antitumor B and tilorone (author's transl)].
    Cai HY; Shu YJ; Wang GQ; Wu AR; Lin PZ; Liu SF; Li MX
    Zhonghua Zhong Liu Za Zhi; 1980; 2(2):92-5. PubMed ID: 7418605
    [No Abstract]   [Full Text] [Related]  

  • 31. Keratopathy in rats after treatment with tilorone.
    Lüllmann-Rauch R
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(4):377-83. PubMed ID: 3710194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
    Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph AC; Becker G; Osterhage J; Jost WH; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M;
    J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
    Cudkowicz ME; van den Berg LH; Shefner JM; Mitsumoto H; Mora JS; Ludolph A; Hardiman O; Bozik ME; Ingersoll EW; Archibald D; Meyers AL; Dong Y; Farwell WR; Kerr DA;
    Lancet Neurol; 2013 Nov; 12(11):1059-67. PubMed ID: 24067398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of tilorone on experimental rat silicosis].
    Cheng YH; Yu XF; Liu FY; Han SL; Hou YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Feb; 5(1):25-8. PubMed ID: 6194906
    [No Abstract]   [Full Text] [Related]  

  • 35. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Meininger V; Asselain B; Guillet P; Leigh PN; Ludolph A; Lacomblez L; Robberecht W;
    Neurology; 2006 Jan; 66(1):88-92. PubMed ID: 16401852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of tilorone on carcinogenesis of the esophagus by N-nitrososarcosine ethylester in rats (author's transl)].
    Cai HY; Lin PZ; Guan XJ; Han R; Zhu TX; Gu QM
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):186-9. PubMed ID: 553794
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of tilorone on mycobacterial infections of mice.
    Levy L; Aizer F; Ng H; Welch TM
    Lepr Rev; 1978 Sep; 49(3):215-22. PubMed ID: 357869
    [No Abstract]   [Full Text] [Related]  

  • 38. The mode of inhibition of herpes simplex and vesicular stomatitis ocular viral infections in the rabbit and hamster by an interferon inducer tilorone dihydrochloride.
    Tokumaru T
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):289-301. PubMed ID: 168623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group.
    Miller RG; Petajan JH; Bryan WW; Armon C; Barohn RJ; Goodpasture JC; Hoagland RJ; Parry GJ; Ross MA; Stromatt SC
    Ann Neurol; 1996 Feb; 39(2):256-60. PubMed ID: 8967757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-glutamate therapy in amyotrophic lateral sclerosis: a trial using lamotrigine.
    Eisen A; Stewart H; Schulzer M; Cameron D
    Can J Neurol Sci; 1993 Nov; 20(4):297-301. PubMed ID: 7906190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.